(Q36889715)

16 August 2017

title

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform (English)

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

16 August 2017

Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform (English)

1 reference

22 November 2024

1 reference

1 reference

immunoglobulin fragments

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

9

C. Halin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

author name string

D. Neri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

B. Carnemolla

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

A. Nissim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

A. Leprini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

G. Querzè

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

E. Balza

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

A. Pini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

L. Tarli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

P. Neri

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

L. Zardi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

G. Winter

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9359110

22 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9359110

22 November 2024

publication date

1 November 1997

1 reference

16 August 2017

November 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9359110

full work available at URL

22 November 2024

http://www.nature.com/articles/nbt1197-1271

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

http://www.nature.com/articles/nbt1197-1271.pdf

22 November 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

22 November 2024

1 reference

16 August 2017

volume

15

1 reference

16 August 2017

issue

12

1 reference

16 August 2017

page(s)

1271-1275

1 reference

The promise and pitfalls of monoclonal antibody therapeutics

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

Prevention of manifest metastasis with monoclonal antibodies: A novel approach to immunotherapy of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

Anatomy of the antibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

Phage antibodies: filamentous phage displaying antibody variable domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

Intralesional radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Stromal involvement in malignant growth

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Single-chain antigen-binding proteins

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Efficient one-step direct labelling of recombinant antibodies with technetium-99m

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [gamma-32P]-ATP.

1 reference

https://api.crossref.org/works/10.1038%2FNBT1197-1271

7 January 2021

https://api.crossref.org/works/10.1038/NBT1197-1271

7

10

163

P Carter

1992

1 reference

22 November 2024

8

11

1271

P Pack

1993

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

22 November 2024

11

52

3402

T Yokota

1992

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

22 November 2024

25

10

779

JD Marks

1992

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

22 November 2024

29

54

2643

S Folli

1994

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

22 November 2024

32

53

4026

GP Adams

1993

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

22 November 2024

33

54

6176

DJ King

1994

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

22 November 2024

34

56

3055

S Hu

1996

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

22 November 2024

44

11

620

U Jönsson

1991

1 reference

https://api.crossref.org/works/10.1038/NBT1197-1271

22 November 2024

Identifiers

DOI

10.1038/NBT1197-1271

1 reference

Dimensions Publication ID

16 August 2017

1019584452

0 references

1 reference